Form 4: BIO-TECHNE CEO Reports Stock Transaction
Insider Transaction (Form 4)
Kim Kelderman, Chief Executive Officer and a Director of BIO-TECHNE Corp, reported multiple transactions in common stock on August 15, 2026.
Summary
- Option exercise/conversion: acquired 21,470 Common Stock on August 15, 2026; holds 93,583 after (Direct).
- Tax/exercise-price withholding: disposed of 10,821 Common Stock at $72.40 ($783,440) on August 15, 2026; holds 82,762 after (Direct).
- Option exercise/conversion: disposed of 554 Performance Restricted Stock Units on August 15, 2026; holds 8,319 after (Direct).
- Disposition to the issuer: disposed of 8,319 Performance Restricted Stock Units on August 15, 2026 (Direct).
- Disposition to the issuer: disposed of 22,389 Performance Stock Options (Right to Buy) on August 15, 2026; holds 1,492 after (Direct).
- Option exercise/conversion: disposed of 588 Performance Restricted Stock Units on August 15, 2026; holds 8,835 after (Direct).
- Disposition to the issuer: disposed of 8,835 Performance Restricted Stock Units on August 15, 2026 (Direct).
- Disposition to the issuer: disposed of 24,324 Performance Stock Options (Right to Buy) on August 15, 2026; holds 1,621 after (Direct).
- Option exercise/conversion: disposed of 8,543 Restricted Stock Units on August 15, 2026; holds 8,544 after (Direct).
- Option exercise/conversion: disposed of 11,785 Restricted Stock Units on August 15, 2026; holds 23,569 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Kim Kelderman — Director, Officer (Chief Executive Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-15 | Option exercise/conversion | Common Stock | 21,470 | — | — | 93,583 |
| 2026-08-15 | Tax/exercise-price withholding | Common Stock | 10,821 | $72 | $783.4K | 82,762 |
| 2026-08-15 | Option exercise/conversion | Performance Restricted Stock Units | 554 | — | — | 8,319 |
| 2026-08-15 | Disposition to the issuer | Performance Restricted Stock Units | 8,319 | — | — | 0 |
| 2026-08-15 | Disposition to the issuer | Performance Stock Options (Right to Buy) | 22,389 | — | — | 1,492 |
| 2026-08-15 | Option exercise/conversion | Performance Restricted Stock Units | 588 | — | — | 8,835 |
| 2026-08-15 | Disposition to the issuer | Performance Restricted Stock Units | 8,835 | — | — | 0 |
| 2026-08-15 | Disposition to the issuer | Performance Stock Options (Right to Buy) | 24,324 | — | — | 1,621 |
| 2026-08-15 | Option exercise/conversion | Restricted Stock Units | 8,543 | — | — | 8,544 |
| 2026-08-15 | Option exercise/conversion | Restricted Stock Units | 11,785 | — | — | 23,569 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-15 | Option exercise/conversion (21,470 shares) |
| 2026-08-15 | Tax/exercise-price withholding (10,821 shares) |
| 2026-08-15 | Option exercise/conversion (554 shares) |
| 2026-08-15 | Disposition to the issuer (8,319 shares) |
| 2026-08-15 | Disposition to the issuer (22,389 shares) |
| 2026-08-15 | Option exercise/conversion (588 shares) |
| 2026-08-15 | Disposition to the issuer (8,835 shares) |
| 2026-08-15 | Disposition to the issuer (24,324 shares) |
| 2026-08-15 | Option exercise/conversion (8,543 shares) |
| 2026-08-15 | Option exercise/conversion (11,785 shares) |
Keywords
insider transaction, Form 4, TECH, BIO-TECHNE Corp, neutral, Kim Kelderman
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.